MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

MDT

84.21

+0.41%↑

VEEV

227.67

+3.34%↑

A

106.91

+1.84%↑

WBA

11.03

+0.46%↑

CHE

546.34

-6.7%↓

Search

ResMed Inc

Slēgts

SektorsVeselības aprūpe

236.07 9.93

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

213.76

Max

239.53

Galvenie mērījumi

By Trading Economics

Ienākumi

33M

345M

Pārdošana

62M

1.3B

P/E

Sektora vidējais

24.867

57.333

EPS

2.43

Dividenžu ienesīgums

1.01

Peļņas marža

26.88

EBITDA

-79M

362M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+23.32% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

1.01%

2.63%

Nākamais dividenžu datums

2025. g. 12. jūn.

Nākamais Ex dividenžu datums

2025. g. 8. maijs

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-3.5B

31B

Iepriekšējā atvēršanas cena

226.14

Iepriekšējā slēgšanas cena

236.07

ResMed Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2024. g. 24. jūn. 17:43 UTC

Galvenie tirgus virzītāji

Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update

2024. g. 7. nov. 03:53 UTC

Tirgus saruna

U.S. Tariffs Could Force Moves by Australian Med-Techs -- Market Talk

2024. g. 25. okt. 09:10 UTC

Peļņas

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

2024. g. 25. okt. 08:35 UTC

Peļņas

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

2024. g. 27. jūn. 16:01 UTC

Peļņas

ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. -- Barrons.com

2024. g. 24. jūn. 17:28 UTC

Galvenie tirgus virzītāji

ResMed, Inspire Medical Shares Down After Eli Lilly Provides Sleep Apnea Study Update

2024. g. 26. apr. 20:12 UTC

Peļņas

These Stocks Moved the Most Today: Alphabet, Microsoft, Intel, Snap, Exxon, Roku, Skechers, ResMed, and More -- Barrons.com

2024. g. 26. apr. 20:09 UTC

Peļņas

How 'Megatrends' Like Weight-Loss Drugs And Smartwatches Are Bolstering ResMed -- IBD

2024. g. 26. apr. 14:01 UTC

Peļņas

ResMed Soars To Eight-Month High As Quarterly Report Wipes Out Weight-Loss Woes -- IBD

Salīdzinājums

Cenas izmaiņa

ResMed Inc Prognoze

Cenas mērķis

By TipRanks

23.32% augšup

Prognoze 12 mēnešiem

Vidējais 264.44 USD  23.32%

Augstākais 290 USD

Zemākais 240 USD

Pamatojoties uz 14 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi ResMed Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

14 ratings

9

Pirkt

5

Turēt

0

Pārdot

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.